Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schirner

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|October 31, 2000
De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loopZ von Marschall, T Cramer, M Höcker, et al.
International Journal of Cancer|April 9, 1998
De novo expression of the alpha5beta1-fibronectin receptor in HT29 colon-cancer cells reduces activity of C-SRC. Increase of C-SRC activity by attachment on fibronectinR Schmidt, M Streit, R Kaiser, et al.
Neuroimage. Clinical|July 24, 2018
Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain modelsJ Zimmermann, A Perry, M Breakspear, et al.
Cancer Research|April 29, 2000
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administrationJ M Wood, G Bold, E Buchdunger, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|October 31, 2000
De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loopZ von Marschall, T Cramer, M Höcker, et al.
International Journal of Cancer|April 9, 1998
De novo expression of the alpha5beta1-fibronectin receptor in HT29 colon-cancer cells reduces activity of C-SRC. Increase of C-SRC activity by attachment on fibronectinR Schmidt, M Streit, R Kaiser, et al.
Neuroimage. Clinical|July 24, 2018
Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain modelsJ Zimmermann, A Perry, M Breakspear, et al.
Cancer Research|April 29, 2000
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administrationJ M Wood, G Bold, E Buchdunger, et al.
Pageof 4